L-Threonolactone
Product Specifications
UNSPSC Description
L-Threonolactone ((3R,4S)-3,4-Dihydroxyoxolan-2-one) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Target Antigen
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/l-threonolactone.html
Solubility
10 mM in DMSO
Smiles
O[C@@H](CO1)[C@@H](O)C1=O
Molecular Weight
118.09
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-W357137/L-Threonolactone-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W357137/
Clinical Information
No Development Reported
CAS Number
21730-93-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2402539-01 0.05 mg
THY1/CD90 Mouse anti-Human Monoclonal (aa17-132)(7E1B11) Antibody
Ask
View Details MBS2402539-02 5x 0.05 mg
THY1/CD90 Mouse anti-Human Monoclonal (aa17-132)(7E1B11) Antibody
Ask
View Details